A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)

Clinical trial NCT00770510 · COMPLETED

Trial details

NCT number: NCT00770510
Sponsor: Eisai Co., Ltd.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Primary Insomnia

Start date: 2008-09-01
Primary completion: 2010-05-01
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.